ROSS ROBERT W. 4
4 · Surface Oncology, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
ROSS ROBERT W.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+400,000→ 400,000 totalExercise: $0.69Exp: 2033-03-01→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The Options shall vest in full on February 8, 2024, so long as the reporting person remains an employee or other service provider of the Issuer on such date.